Genetic Markers in Patients With Colorectal Cancer

Completed

Conditions studied: Colorectal Cancer

In brief

RATIONALE: Determination of genetic markers for colorectal cancer may improve the identification of patients who are at highest risk for relapse. PURPOSE: This clinical trial is studying the importance of genetic markers for detecting relapse in patients with colorectal cancer.

Key facts

Study ID

NCT00014079

Run by

Alliance for Clinical Trials in Oncology

People needed

675

Starts

1997-09-01

Expected to finish

2005-05-01

Last updated by the study team

2016-07-13

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• CCOP - Mayo Clinic Scottsdale Oncology Program — Scottsdale, Arizona, United States
• Mayo Clinic - Jacksonville — Jacksonville, Florida, United States
• Mayo Clinic Cancer Center — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.